Intelgenx Technologies (FRA:0IL) Current Accrued Expense : €1.31 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Intelgenx Technologies Current Accrued Expense?

Intelgenx Technologies's Current Accrued Expense for the quarter that ended in Mar. 2024 was €1.31 Mil.

Intelgenx Technologies's quarterly Current Accrued Expense declined from Sep. 2023 (€2.99 Mil) to Dec. 2023 (€1.15 Mil) but then increased from Dec. 2023 (€1.15 Mil) to Mar. 2024 (€1.31 Mil).

Intelgenx Technologies's annual Current Accrued Expense declined from Dec. 2021 (€2.04 Mil) to Dec. 2022 (€0.55 Mil) but then increased from Dec. 2022 (€0.55 Mil) to Dec. 2023 (€1.15 Mil).

Intelgenx Technologies Current Accrued Expense Historical Data

The historical data trend for Intelgenx Technologies's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intelgenx Technologies Current Accrued Expense Chart

Intelgenx Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Current Accrued Expense

Get a 7-Day Free Trial

1.75

1.64

2.04

0.55

1.15

Intelgenx Technologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Current Accrued Expense	Get a 7-Day Free Trial															2.35	2.58	2.99	1.15	1.31

Intelgenx Technologies Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Intelgenx Technologies Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Intelgenx Technologies's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Intelgenx Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intelgenx Technologies Corp (FRA:0IL) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

IGXT:USA IGX:Canada

Address

6420 Abrams, Ville Saint Laurent, QC, CAN, H4S 1Y2

Website

https://www.intelgenx.com

Intelgenx Technologies Corp is an oral drug delivery company. The company is focused on the development and manufacturing of pharmaceutical oral films based on its proprietary VersaFilmTM technology platform. Intelegenx focuses on the development of novel oral immediate-release and controlled-release products for the pharmaceutical market. It offers a comprehensive portfolio of pharmaceutical services, including pharmaceutical R&D, clinical monitoring, regulatory support, tech transfer and manufacturing scale-up, and commercial manufacturing. Its geographical segments are Europe, Canada, and United States.

Intelgenx Technologies Headlines

No Headlines